• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    US FDA Approves First Treatment for Rare Disease in Males

    REUTERS

    Stealth, Barth Community Await FDA Verdict With All at Stake

    BIOSPACE

    Stealth`s Flight Path Returns to FDA for Rejected Barth Drug

    BIOSPACE

    Stealth Bio Submits Rare Disease Application for The Third Time

    PR NEWSWIRE

    StealthBio Submits Rare Disease Application for The Third Time

    FIERCE BIOTECH

    FDA Rejects Reconsideration of Stealth`s Ultrarare Disease Med

    FIERCE BIOTECH

    Stealth to Cut Jobs After FDA Rejects Therapy for Rare Disorder

    REUTERS

    FDA delays decision on Stealth` rare genetic disorder drug

    REUTERS

    FDA Panel Votes For Elamipretide In Barth Syndrome

    PR NEWSWIRE

    After agony, FDA adcomm favors Stealth`s ultra-rare disease drug

    FIERCE BIOTECH

    FDA again raises doubts on Stealth`s ultra-rare disease drug ahead

    ENDPTS

    Stealth Biotherapeutics` Barth Syndrome NDA Receives Priority Review Designation

    PR NEWSWIRE

    Stealth Bio gets FDA adcomm for previously rejected ultra-rare disease drug

    ENDPTS

    Stealth Announces FDA Acceptance of NDA for Elamipretide for the Barth Syndrome

    PR NEWSWIRE

    Rare disease drugmaker files for approval on adequate trial data; FDA objects

    ENDPTS

    Stealth BioTherapeutics Joins the Rare Disease Company Coalition

    PR NEWSWIRE

    Stealth & Evotec Advance New Compound

    CONTRACT PHARMA

    Another IPO frenzy? Two US biotechs head to Hong Kong for a public market debut

    ENDPTS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.